FDA investigating website, Aid Access, for shipping abortion pills, Mifiprex RU-486 to women
The Food and Drug Administration (FDA) is investigating a new website, Aid Access, which provides abortion pills to women in the U.S. without medical supervision. The site connects women to online physicians for More...
HHS terminates the FDA and ABR ties to stop tax money from being used to fund fetal tissue research
The U.S. Department of Health and Human Services (HHS) has terminated the contract between the Food and Drug Administration (FDA) and Advanced Bioscience Resources (ABR) which would have used taxpayer dollars to More...
Pro-lifers urge HHS to end taxpayer funds for aborted fetal tissue research
National and state pro-life leaders sent a letter this week to U.S. Department of Health and Human Services Secretary Alex Azar urging the government to end the taxpayer-funded use of aborted fetal tissue for More...
When Meds Cause Problems: 5 Facts About Medication Injury Claims
Did you know that the Food and Drug Administration doesn’t actually test medications before approving them for use? Instead, their Center for Drug Evaluation and Research will review and research results and information More...
We Need to Be Realistic With Kids About Vaping
Abstinence from smoking is a good thing. Long-term risks from smoking should never be promoted, and while the idea of abstinence is admirable, this doesn’t mean that everyone will follow it. Discouraging younger More...
TRANSCRIPT: President Trump’s 2018 State of the Union Address
President Donald Trump gave his first State of the Union address on Tuesday. Read the President’s speech as prepared for delivery and released by the White House. Mr. Speaker, Mr. Vice President, Members More...
Liberty Counsel challenges California’s first amendment violations, forcing pro-lifers to promote abortion
Liberty Counsel filed an amicus brief today in National Institute of Family and Life Advocates (NIFLA) v. Becerra, one of four cases brought before the Supreme Court by crisis pregnancy centers challenging the More...
Chagas disease: Benznidazole IND receives FDA clearance
In a follow-up on a report on KaloBios Pharmaceutical’s Chagas disease drug, benznidazole, the California based biopharmaceutical company announced today its Investigational New Drug (IND) application More...
What To Know About the EpiPen Right Now
The EpiPen has been a source of tremendous controversy over the past year. Manufactured by the Mylan company, the EpiPen is a medical device available by prescription designed to inject doses of epinephrine through More...
Dietary Supplements: The Face of a Self-Regulating Industry
The pressure to look great weighs heavily on many. From people who want to lose weight to improve their overall health to those who want to lose weight to fit their ideal beauty standards, the dietary supplement More...
The Different Treatment Approaches for Drug Addiction
Finding the most suitable treatment approach for drug addiction victims is an overwhelming task for both addicts and their family members. The task in itself may seem impossibly to achieve. Some patients take years More...
GlaxoSmithKline Urges Third Circuit to Ignore Ruling in Fosamax Case
GlaxoSmithKline PLC has asked the Third Circuit Appeals Court to ignore the ruling in a product liability case involving the drug Fosamax when deciding whether to revive a suit brought on by buyers of Wellbutrin. More...
Syracuse Clinic Treats Head Lice with Hot Air
A head lice clinic in Syracuse, New York is taking a new approach to treatment: hot air. The treatment is designed to give patients an alternative to conventional treatments that include pesticide-based shampoos, More...
Praise for the REINS Act as it moves to the Senate, ‘restoring Article I of the Constitution’ ‘reclaiming its legislative power’
Following the passage of the Regulations from the Executive in Need of Scrutiny (REINS) Act, H.R. 26, FreedomWorks CEO Adam Brandon commented: “We’re pleased to see regulatory reform be the focus of the first More...
Profounda receives FDA Orphan Drug Designation for miltefosine for treating Primary Amebic Meningoencephalitis (PAM)
Profounda, Inc. announced Friday that it has received, the US Food and Drug Administration’s (FDA) Orphan Drug Designation for the treatment of Primary Amebic Meningoencephalitis (PAM) with miltefosine. More...
US Senate to fine pharmacists who refuse to dispense Plan B
Senate Democrats have introduced a bill that would impose crushing fines on pharmacists who refuse to personally dispense Plan B pills, an “emergency contraception,” and a potential abortifacient, removing conscience More...
FDA passes Mifeprex changes, reducing cost for abortions despite risk to women
The Food and Drug Association (FDA) changed the regimen for mifepristone (Mifeprex), significantly reducing the obstacles, burden, and cost to abortionists. The move includes approval of new labeling for the abortion More...
New Hampshire: state loses valid ‘right to know’ battle over Planned Parenthood delays
A New Hampshire court ruled Tuesday that the state’s Department of Health and Human Services was wrong to wait for permission from Planned Parenthood before releasing documents the agency was legally required More...
ADF files brief to make New Hampshire funding of Planned Parenthood records public
Alliance Defending Freedom attorneys filed a brief with the New Hampshire Supreme Court Wednesday to release all documents related to the state’s funding of abortion facilities and its continuing failure to regulate More...
Prevalent Poison: The Shocking Stats Behind Nursing Home Drugging
When people send their loved ones to a nursing home, they expect that they will be taken care of. But, some new findings suggest that elderly patients are being abused in these facilities. Here are some ways to More...
